Literature DB >> 12874447

Application of high-density DNA microarray to study smoke- and hydrogen peroxide-induced injury and repair in human bronchial epithelial cells.

Ken Yoneda1, Mary Mann-Jong Chang, Ken Chmiel, Yin Chen, Reen Wu.   

Abstract

Recent advances in high-density DNA microarray technique allow the possibility to analyze thousands of genes simultaneously for their differential gene expression patterns in various biologic processes. Through clustering analysis and pattern recognition, the significance of these differentially expressed genes can be recognized and correlated with the biologic events that may take place inside the cell and tissue. High-density DNA microarray nylon membranes were used to explore gene expression and regulation associated with smoke- and hydrogen peroxide-induced injury and repair in differentiated human bronchial epithelial cells in vitro. At least three phases of change in gene expression could be recognized. The first phase seems to be an immediate event in response to oxidant injury. This phase includes the induction of bcl-2 and mdm2 genes that are involved in the regulation of apoptosis, and the mitogen-activated protein kinase phosphatase 1 that functions as a regulator for various mitogen-activated protein kinase activities. The second phase, usually 5 h later, includes the induction of various stress proteins and ubiquitin, which are important in providing the chaperone mechanism and the turnover of damaged macromolecules. The third phase, which is 5 to 10 h later, includes the induction of genes that seem to be involved in reducing oxidative stress by metabolizing the cellular level of reactive oxygen species. In this phase, enzymes associated with tissue and cell remodeling are also elevated. These results demonstrated a complex gene expression array by bronchial epithelial cells in response to a single insult of oxidants that are relevant to environmental pollutants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874447     DOI: 10.1097/01.asn.0000078023.30954.05

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

1.  Regulation of expression of the rat orthologue of mouse double minute 2 (MDM2) by H(2)O(2)-induced oxidative stress in neonatal rat cardiac myocytes.

Authors:  Sampsa Pikkarainen; Robert A Kennedy; Andrew K Marshall; El Li Tham; Kenneth Lay; Thomas A Kriz; Balvinder S Handa; Angela Clerk; Peter H Sugden
Journal:  J Biol Chem       Date:  2009-07-28       Impact factor: 5.157

2.  Small proline-rich proteins (SPRR) function as SH3 domain ligands, increase resistance to injury and are associated with epithelial-mesenchymal transition (EMT) in cholangiocytes.

Authors:  Anthony J Demetris; Susan Specht; Isao Nozaki; John G Lunz; Donna Beer Stolz; Noriko Murase; Tong Wu
Journal:  J Hepatol       Date:  2007-12-17       Impact factor: 25.083

Review 3.  Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

Authors:  John J Mieyal; Molly M Gallogly; Suparna Qanungo; Elizabeth A Sabens; Melissa D Shelton
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

4.  Sprr2f protects against renal injury by decreasing the level of reactive oxygen species in female mice.

Authors:  Kieu My Huynh; Anny Chuu-Yun Wong; Bo Wu; Marc Horschman; Hongjuan Zhao; James D Brooks
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-05

5.  Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease.

Authors:  Mirva J Peltoniemi; Paula H Rytilä; Terttu H Harju; Ylermi M Soini; Kaisa M Salmenkivi; Lloyd W Ruddock; Vuokko L Kinnula
Journal:  Respir Res       Date:  2006-10-25

6.  Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients.

Authors:  Terttu H Harju; Mirva J Peltoniemi; Paula H Rytilä; Ylermi Soini; Kaisa M Salmenkivi; Philip G Board; Lloyd W Ruddock; Vuokko L Kinnula
Journal:  Respir Res       Date:  2007-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.